Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)
NCT00348686Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2006
- Primary completion
- Jun 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by AstraZeneca. Started Jun 2006; status: completed.
02
Drugs
candesartan
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00348686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348686.